Current Project / EChiLiBRiST
Horizon Europe Research & Innovation Initiative
EChiLiBRiST Project Specifications
- Project Acronym: EChiLiBRiST
- Project Title: Enhancing Children’s Lives with Biomarkers for Risk Stratification and Triage
- Project Coordinator: ISGlobal (Quique Bassat)
- ITClinical Involvement: March 2024 – August 2027
About the Project
The EChiLiBRiST project aims to develop a rapid point-of-care test for fever biomarkers in children. This enables better risk stratification and improves survival outcomes in low-income countries.
The project spans five years. It covers the engineering of the diagnostic device, clinical trials in Ethiopia, Gabon, and Mozambique, and an evaluation of the cost-effectiveness and social acceptability of the intervention.
ITClinical’s Strategic Contribution
ITClinical leads key software engineering and regulatory monitoring pipelines to secure clinical trial accuracy.
Our clinical team keeps field records aligned with protocol requirements, ICH mandates, and GCP guidelines to maximize scientific validity.
We also deploy our Pharmacovigilance, Logistics, and Clinical Trial Management platforms. Over 15 years of validation expertise in regulated environments drives optimized trial data entry.